Siemens Healthineers

What Siemens Healthineers does

Siemens Healthineers AG is a publicly traded healthcare technology company (Frankfurt Stock Exchange: SHL) that was spun off from Siemens AG in 2018 and operates from its registered headquarters in Forchheim, Germany. The company designs, manufactures, and services medical imaging systems (MAGNETOM MRI scanners ranging from 0.55T to 3T, NAEOTOM Alpha photon-counting CT, Artis interventional imaging with AI-based Optiq, Acuson ultrasound), laboratory diagnostics automation (Atellica platform with CDC HoSt-TT certified immunoassays), cancer care/radiotherapy systems (Varian Ethos with HyperSight, linear accelerators, Eclipse treatment planning), and point-of-care testing devices (epoc Blood Analysis System). Its portfolio is differentiated by 23,000+ technical IP rights, €1.5 billion annual R&D investment, and AI capabilities embedded across imaging, treatment planning, and laboratory workflows.

The company serves hospitals, health systems, clinical laboratories, and cancer care centers globally, with a stated footprint in over 70 countries and relationships with 90% of leading hospitals worldwide. Its go-to-market combines direct enterprise field sales for large healthcare systems, authorized distributors for mid-market accounts, and Value Partnerships/consulting engagements that bundle technology, services, and operational optimization into long-term contracts. Revenue is generated through capital equipment sales (MRI, CT, radiotherapy, lab analyzers), recurring service and support contracts on the installed base, consumables and reagents for diagnostic systems, and managed-service partnerships.

Siemens Healthineers is currently navigating a period of strategic realignment: Siemens AG is pursuing shareholder approval to divest its remaining majority stake, the company is exploring a carve-out of its Diagnostics unit amid structural weakness in the Chinese market, and management trimmed FY2026 comparable revenue growth guidance to 4.5%-5%. Offsetting this, the company is investing in growth areas including photon Flash radiotherapy (ARPA-H funded), AI-enhanced interventional imaging, PET radiopharmaceuticals (via AAA acquisition), and geographic expansion in Saudi Arabia and Africa. CEO Bernd Montag leads the company with announced leadership changes accompanying the strategic review.

Name

Siemens Healthineers

Legal name

Siemens Healthineers AG

Website

https://siemens-healthineers.com

Company type

Public

Founded year

2018

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Siemens Healthineers AG is a publicly traded healthcare technology company providing medical imaging, laboratory diagnostics, cancer care, and point-of-care testing solutions to hospitals and health systems across 70+ countries, with AI-embedded product portfolio.

Ownership category

akta.pro rank

Product category

Medical Imaging Equipment

NAICS

Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391), Software Publishers (5132)

SIC

Surgical & Medical Instruments & Apparatus (3841), Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

X-ray & Fluoroscopy Systems (HLAHABAA)

akta.pro secondary industries

Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG), Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ), Portable, Mobile & Point-of-Care Imaging Systems (HLAHABAL), Contrast Media Injectors & Radiology Accessories (HLAHABAK)

Keywords

• Medical imaging equipment
• Laboratory diagnostics systems
• Cancer care solutions
• AI-powered radiology
• In-vitro diagnostics

Headquarters

HQ city

Malvern

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical Imaging Equipment Sales: Sale of imaging equipment including MRI systems, CT scanners, X-ray, ultrasound, and molecular imaging systems. Equipment sales represent core revenue with long sales cycles targeting healthcare systems and hospitals globally.
2. Laboratory Diagnostics: Laboratory diagnostic systems, reagents, and consumables for clinical chemistry, immunoassay, hematology, and molecular diagnostics. Includes the Atellica platform family and related assay products.
3. Advanced Therapies (Varian): Radiotherapy and cancer care solutions including linear accelerators, treatment planning software, and related services following Varian acquisition.
4. Service and Support Contracts: Preventive maintenance, repair services, software updates, and technical support contracts for installed equipment base. Provides recurring revenue stream from existing customer installations.
5. Value Partnerships and Consulting: Long-term partnerships with healthcare providers offering technology management, operational consulting, and performance optimization services.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Core offering

Siemens Healthineers manufactures and sells medical imaging systems (MRI, CT, X-ray, ultrasound, mammography), laboratory diagnostics platforms and assays, and cancer care/radiotherapy solutions including Varian systems. The company complements this hardware portfolio with AI-enabled digital health software, value partnership consulting, and recurring service contracts across more than 70 countries.

Product overview

Siemens Healthineers offers a comprehensive healthcare technology portfolio organized around several core platforms: Medical Imaging (including MAGNETOM MRI scanners, NAEOTOM Alpha photon-counting CT, Artis interventional systems, Acuson Maple ultrasound, and mammography solutions), Laboratory Diagnostics (featuring the Atellica platform with automated immunoassay and clinical chemistry systems), Cancer Care (through Varian radiotherapy systems including Ethos with HyperSight), Point-of-Care Testing, and Digital Solutions & Automation. The company provides these as both standalone products and integrated enterprise solutions, complemented by Value Partnerships, Services, and Healthcare IT offerings. Key software products include Syngo.CT Coronary Cockpit and Syngo PCI Connect for cardiac interventions. The portfolio spans diagnostic imaging, in-vitro diagnostics, radiotherapy, and digital health, with AI capabilities embedded across imaging systems, workflow automation, and data analysis platforms.

Differentiator

Problem solved

Functional benefit

Brands

• Varian: Cancer care and radiotherapy solutions business area providing radiation therapy systems and cancer treatment technology
• Atellica
• MAGNETOM
• Acuson
• Artis

Products and services

• MAGNETOM MRI Scanners Superconducting-magnet MRI systems spanning 0.55T to 3T field strengths, used by hospitals and imaging centers for diagnostic imaging across neurology, cardiology, and oncology.
• NAEOTOM Alpha Photon-Counting CT Photon-counting CT scanner that delivers improved diagnostic precision and reduced radiation exposure relative to conventional CT, deployed in hospitals and advanced imaging centers.
• Artis Interventional Imaging Systems Interventional imaging portfolio (floor, biplane, ceiling, and robotic versions) featuring AI-based Optiq imaging technology that improves image quality while reducing radiation exposure during interventional procedures, sold to hospitals and cath labs.
• Acuson Maple Ultrasound Portable AI-powered ultrasound system launched in November 2023 for point-of-care diagnostics in hospitals, ICUs, and remote care settings.
• Atellica Laboratory Diagnostics Platform Automated clinical chemistry and immunoassay analyzer platform used by hospital and independent laboratories for high-throughput diagnostic testing, including assays such as the CDC HoSt-TT certified Testosterone II assay.
• epoc Blood Analysis System Point-of-care blood gas analysis system manufactured in Ottawa for rapid bedside diagnostics in hospitals, emergency departments, and critical care settings.
• Varian Ethos with HyperSight Radiotherapy System AI-powered radiotherapy system from the Varian business area that enables daily tumor scans and real-time adaptation of cancer treatment plans based on patient anatomy changes, sold to cancer centers and hospitals.
• Syngo.CT Coronary Cockpit and Syngo PCI Connect Integrated end-to-end software solution for CT-guided percutaneous coronary interventions covering the full workflow from diagnosis and plaque analysis through planning and cath lab procedural guidance, used by hospitals and cardiac intervention teams.
• Atellica IM Testosterone II (TSTII) Assay CDC HoSt-TT certified immunoassay for total testosterone measurement with results equivalent to the mass spectrometry gold standard, run on Atellica IM and Atellica CI analyzers.
• Value Partnerships and Consulting Long-term strategic partnership offering healthcare providers bundled technology, services, and operational consulting to optimize clinical and business performance.
• Equipment Service and Support Contracts Recurring preventive maintenance, repair, software update, and technical support contracts covering the installed base of Siemens Healthineers imaging, diagnostics, and radiotherapy equipment.

Quantifiable outcome

• Nearly 75% of critical clinical decisions influenced by Siemens Healthineers solutions
• +1 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability20 records

Feature7 records

Partnerships

Twelve partnerships are on record, tiered minor, major and core.

• Imagion BiosystemsminorStrategic or Co-development Partner · 6 July 2026Extended collaboration adding U.S. partnership to support Imagion's planned multi-site Phase 2 study for its MagSense HER2 imaging agent. Siemens Healthineers will optimize MRI protocols and provide limited technical support to clinical sites.
• Alberta Cancer FoundationmajorStrategic or Co-development Partner · 23 June 2026800 million USD cancer innovation partnership including 175 million USD from Siemens Healthineers for cancer care equipment, treatment centers, and research facilities in Alberta, Canada.
• Pantai Hospital Kuala Lumpur (IHH Healthcare)minorStrategic or Co-development Partner · 22 June 2026Installation of AI-powered radiotherapy system (Varian Ethos with HyperSight) at Pantai Hospital's Cancer Centre, enabling daily tumor scans for personalized treatment plans. Hospital provides public-private partnership radiotherapy services.
• Penn MedicineminorStrategic or Co-development Partner · 22 June 2026Support for Penn Medicine's community health fair providing mobile mammography and ultrasound services to underserved communities in West Philadelphia. Mobile mammogram van has provided over 40% of mammograms to uninsured patients.
• IAEA Rays of Hope InitiativemajorStrategic or Co-development Partner · 20 June 2026Partnership through IAEA's Rays of Hope cancer care initiative delivering training, technology, and expertise to countries with limited access to radiotherapy and medical imaging services. The initiative has secured over 90 million euros in contributions from governments and private-sector partners.
• ARPA-H SHIELD ProjectmajorStrategic or Co-development Partner · 11 June 2026Nearly 7 million USD grant from ARPA-H for SHIELD project to advance cyber resilience of medical devices. Siemens Healthineers serves as principal research institution for exa-scale simulation developing autonomous cybersecurity solutions for medical imaging equipment.
• MEDIOT AI (ABA Life)majorStrategic or Co-development Partner · 5 June 2026Strategic partnership to develop AI-enhanced healthcare infrastructure across Africa and emerging markets. Combines Siemens Healthineers' medical imaging expertise with MEDIOT AI's sovereign AI platforms and MEDIFUS Health Operating System, focusing on AI-assisted diagnosis, smart hospital infrastructure, telehealth, and predictive biomedical maintenance.
• Bharathiar University IndiaminorStrategic or Co-development Partner · 30 May 2026Partnership to establish BU-Varian TPS Training Centre on campus, providing training in advanced radiation treatment planning systems including Eclipse-based technologies (3DCRT, IMRT, VMAT, Brachytherapy). First facility of its kind in India.
• AiM Medical RoboticscoreTechnology or Integration · 26 May 2026Collaboration to integrate AiM's MRI-compatible robotic neurosurgery platform with Siemens MAGNETOM MRI scanners. Development of dedicated software interface enabling bidirectional control and data exchange across 0.55T to 3T MRI systems for real-time, in-bore neurosurgical precision.
• Saudi Ministry of HealthmajorStrategic or Co-development Partner · 11 May 2026MoU signed for regional headquarters and manufacturing facility in Saudi Arabia as part of local expansion strategy in Middle East market.
• ARPA-H (Advanced Research Projects Agency for Health)majorStrategic or Co-development Partner · 3 May 2026ARPA-H awarded Varian, a Siemens Healthineers business, up to 60 million USD over five years for photon Flash radiotherapy development, with Siemens Healthineers contributing an additional 23 million USD cost share (total 83 million USD commitment).
• Novartis (Advanced Accelerator Applications)majorStrategic or Co-development Partner · 27 August 2024Siemens Healthineers agreed to acquire part of Novartis' radiopharmaceutical business for over 200 million euros, specifically the diagnostic arm of Advanced Accelerator Applications (AAA) Molecular Imaging. The deal includes 14 manufacturing sites across France, Spain, Portugal, Italy, and Germany, plus selected assets in Switzerland, expanding Siemens' PET radiopharmaceuticals unit in Europe.

Scale indicators7 records

Recent moves9 records

Expansion highlights7 records

Direct peers

• GE HealthCare: Direct competitor across MRI, CT, X-ray, ultrasound, and patient monitoring. GE HealthCare is the closest large-cap peer to Siemens Healthineers in medical imaging equipment and AI-enabled diagnostics.
• Philips (Royal Philips): Competes head-to-head in diagnostic imaging, image-guided therapy, and healthcare informatics. Philips' Diagnosis & Treatment segment overlaps materially with Siemens Healthineers' imaging portfolio.
• Canon Medical Systems: Subsidiary of Canon Inc. offering MRI, CT, ultrasound, and X-ray systems. Direct peer in cross-sectional imaging with comparable product breadth and global hospital customer base.
• Fujifilm Healthcare: Provides medical imaging systems (X-ray, endoscopy, ultrasound) and enterprise imaging IT. Comparable as a diversified imaging equipment and healthcare IT vendor serving hospitals globally.
• Hologic: Direct competitor in women's health and mammography; the recent UPC patent ruling against Siemens Healthineers' Mammomat B.brilliant illustrates direct product overlap in breast imaging.
• Elekta: Radiotherapy and radiosurgery systems competitor to Varian. Directly comparable as a specialized cancer-care radiotherapy vendor targeting the same oncology customers.

Broad incumbents

• Roche Diagnostics: Larger in-vitro diagnostics incumbent. Overlaps with Siemens Healthineers' Laboratory Diagnostics business (clinical chemistry, immunoassay) as a broad incumbent in the same space.
• Abbott Diagnostics: Broad incumbent in clinical chemistry, immunoassay, and point-of-care diagnostics. Competes with the Atellica platform and epoc Blood Analysis System in hospital and POC testing.
• Danaher (Beckman Coulter Diagnostics): Diagnostics conglomerate via Beckman Coulter. Competes with Siemens Healthineers' clinical chemistry and immunoassay products through its broad hospital diagnostics portfolio.

Emerging players

• Mindray: Chinese medical device manufacturer expanding in patient monitoring, ultrasound, and in-vitro diagnostics. Comparable as a fast-growing emerging player in imaging and diagnostics, particularly relevant given Siemens Healthineers' China exposure.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/157241
• Xx.com/SiemensHealth
• Facebookfacebook.com/SiemensHealthineers

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries1 record

Funding overview

Funding rounds2 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A12 records

Investments7 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Siemens Healthineers